TY - JOUR
T1 - Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia
AU - Takahashi, Tsutomu
AU - Zhou, Shi Yu
AU - Nakamura, Kazue
AU - Tanino, Ryoichiro
AU - Furuichi, Atsushi
AU - Kido, Mikio
AU - Kawasaki, Yasuhiro
AU - Noguchi, Kyo
AU - Seto, Hikaru
AU - Kurachi, Masayoshi
AU - Suzuki, Michio
N1 - Funding Information:
This research was supported in part by Grants-in-Aid for Scientific Research (C) (Nos. 19591346 and 22591275 ) from the Japanese Society for the Promotion of Science , a Research Grant ( 17-2 , 18-6 , and 20-3 ) for Nervous and Mental Disorders from the Ministry of Health and Welfare of Japan , and a research grant from the Research Group of Schizophrenia . The authors are grateful to Ms. Valentina Lorenzetti for assistance in MRI analysis and to Dr. Tomohiro Miyanishi for assistance in collecting the clinical data of the study participants.
PY - 2011/1/15
Y1 - 2011/1/15
N2 - An enlarged volume of the pituitary gland has been reported in the schizophrenia spectrum, possibly reflecting the hypothalamic-pituitary-adrenal (HPA) hyperactivity. However, it remains largely unknown whether the pituitary size longitudinally changes in the course of the spectrum disorders. In the present study, longitudinal magnetic resonance imaging (MRI) data were obtained from 18 patients with first-episode schizophrenia, 13 patients with schizotypal disorder, and 20 healthy controls. The pituitary volume was measured at baseline and follow-up (mean, 2.7. years) scans and was compared across groups. The pituitary volume was larger in the schizophrenia patients than controls at baseline, and both patient groups had significantly larger pituitary volume than controls at follow-up. In a longitudinal comparison, both schizophrenia (3.6%/year) and schizotypal (2.7%/year) patients showed significant pituitary enlargement compared with controls (-1.8%/year). In the schizophrenia patients, greater pituitary enlargement over time was associated with less improvement of delusions and higher scores for thought disorders at the follow-up. These findings suggest that the pituitary gland exhibits ongoing volume changes during the early course of the schizophrenia spectrum as a possible marker of state-related impairments.
AB - An enlarged volume of the pituitary gland has been reported in the schizophrenia spectrum, possibly reflecting the hypothalamic-pituitary-adrenal (HPA) hyperactivity. However, it remains largely unknown whether the pituitary size longitudinally changes in the course of the spectrum disorders. In the present study, longitudinal magnetic resonance imaging (MRI) data were obtained from 18 patients with first-episode schizophrenia, 13 patients with schizotypal disorder, and 20 healthy controls. The pituitary volume was measured at baseline and follow-up (mean, 2.7. years) scans and was compared across groups. The pituitary volume was larger in the schizophrenia patients than controls at baseline, and both patient groups had significantly larger pituitary volume than controls at follow-up. In a longitudinal comparison, both schizophrenia (3.6%/year) and schizotypal (2.7%/year) patients showed significant pituitary enlargement compared with controls (-1.8%/year). In the schizophrenia patients, greater pituitary enlargement over time was associated with less improvement of delusions and higher scores for thought disorders at the follow-up. These findings suggest that the pituitary gland exhibits ongoing volume changes during the early course of the schizophrenia spectrum as a possible marker of state-related impairments.
KW - Hypothalamic-pituitary-adrenal axis
KW - Magnetic resonance imaging
KW - Pituitary gland
KW - Schizophrenia
KW - Schizotypal disorder
UR - http://www.scopus.com/inward/record.url?scp=78650961119&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2010.10.023
DO - 10.1016/j.pnpbp.2010.10.023
M3 - 学術論文
C2 - 21044655
AN - SCOPUS:78650961119
SN - 0278-5846
VL - 35
SP - 177
EP - 183
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
IS - 1
ER -